These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 1768211)
1. Improving the reliability of total and high-density lipoprotein cholesterol measurements. Four testing strategies compared in a high-risk population. Christenson RH; Roeback JR; Watson TE; Hla KM Arch Pathol Lab Med; 1991 Dec; 115(12):1212-6. PubMed ID: 1768211 [TBL] [Abstract][Full Text] [Related]
2. Quality of lipid and lipoprotein measurements in community laboratories. Watson JE; Evans RW; Germanowski J; Caggiula AW; Olson MB; Hauth BA Arch Pathol Lab Med; 1997 Feb; 121(2):105-9. PubMed ID: 9126034 [TBL] [Abstract][Full Text] [Related]
3. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines. Bookstein L; Gidding SS; Donovan M; Smith FA Arch Intern Med; 1990 Aug; 150(8):1653-7. PubMed ID: 2383160 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Dale RA; Jensen LH; Krantz MJ Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684 [TBL] [Abstract][Full Text] [Related]
5. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012 [TBL] [Abstract][Full Text] [Related]
6. Total and high-density lipoprotein cholesterol measurements. Hazards in clinical interpretation. Rivin AU West J Med; 1989 Sep; 151(3):289-91. PubMed ID: 2588565 [TBL] [Abstract][Full Text] [Related]
7. The high-risk and population strategy for occupational health promotion (HIPOP-OHP) study: study design and cardiovascular risk factors at the baseline survey. Okamura T; Tanaka T; Babazono A; Yoshita K; Chiba N; Takebayashi T; Nakagawa H; Yamato H; Miura K; Tamaki J; Kadowaki T; Okayama A; Ueshima H; J Hum Hypertens; 2004 Jul; 18(7):475-85. PubMed ID: 14749712 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II. McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933 [TBL] [Abstract][Full Text] [Related]
9. Results of a province-wide quality assurance program assessing the accuracy of cholesterol, triglycerides, and high-density lipoprotein cholesterol measurements and calculated low-density lipoprotein cholesterol in Ontario, using fresh human serum. McQueen MJ; Henderson AR; Patten RL; Krishnan S; Wood DE; Webb S Arch Pathol Lab Med; 1991 Dec; 115(12):1217-22. PubMed ID: 1768212 [TBL] [Abstract][Full Text] [Related]
10. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events. Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648 [TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio. Luria MH Arch Intern Med; 1988 Nov; 148(11):2493-5. PubMed ID: 3190381 [TBL] [Abstract][Full Text] [Related]
12. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932 [TBL] [Abstract][Full Text] [Related]
13. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes. Temelkova-Kurktschiev T; Hanefeld M Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770 [TBL] [Abstract][Full Text] [Related]
14. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708 [TBL] [Abstract][Full Text] [Related]
15. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data]. Orso Giacone G Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764 [TBL] [Abstract][Full Text] [Related]
16. Association between high-density lipoprotein and cognitive impairment in the oldest old. van Exel E; de Craen AJ; Gussekloo J; Houx P; Bootsma-van der Wiel A; Macfarlane PW; Blauw GJ; Westendorp RG Ann Neurol; 2002 Jun; 51(6):716-21. PubMed ID: 12112077 [TBL] [Abstract][Full Text] [Related]
17. Regression dilution bias in blood total and high-density lipoprotein cholesterol and blood pressure in the Glostrup and Framingham prospective studies. Lewington S; Thomsen T; Davidsen M; Sherliker P; Clarke R J Cardiovasc Risk; 2003 Apr; 10(2):143-8. PubMed ID: 12668912 [TBL] [Abstract][Full Text] [Related]
18. Lipid abnormalities in coronary heart disease: a population-based case-control study. Gupta R; Kaul V; Prakash H; Sarna M; Singhal S; Gupta VP Indian Heart J; 2001; 53(3):332-6. PubMed ID: 11516034 [TBL] [Abstract][Full Text] [Related]